Transmyocardial Laser Revascularization: From Randomized Trials to Clinical Practice. A Review of Techniques, Evidence-Based Outcomes, and Future Directions - 21/08/11
Doi : 10.1016/j.anclin.2008.04.001
Keith B. Allen, MD a, ⁎ 
, James Kelly, MD b, A. Michael Borkon, MD a, R. Scott Stuart, MD a, Emmanuel Daon, MD a, Alexander F. Pak, MD a, George L. Zorn, MD a, Michelle Haines, MD b
, James Kelly, MD b, A. Michael Borkon, MD a, R. Scott Stuart, MD a, Emmanuel Daon, MD a, Alexander F. Pak, MD a, George L. Zorn, MD a, Michelle Haines, MD b a Department of Cardiothoracic Surgery, Mid America Heart Institute, St. Luke’s Hospital, 4320 Wornall Road, Suite 50, Kansas City, MO 64111, USA
b Department of Anesthesiology, Mid America Heart Institute, St. Luke’s Hospital, 4401 Wornall Road, Kansas City, MO 64111, USA
Corresponding author.Abstract |
Cardiac surgeons are increasingly faced with a more complex patient who has developed a pattern of diffuse coronary artery disease that cannot be completely revascularized by CAGB alone. Considering the increased operative and long-term cardiac risks predicted by incomplete revascularization, and the documented operative and long-term benefits associated with sole therapy and adjunctive TMR in randomized patients with diffuse coronary artery disease, increased use of sole therapy and adjunctive TMR therapy is warranted.
Le texte complet de cet article est disponible en PDF.Plan
© 2008
Elsevier Inc. Tous droits réservés.
Vol 26 - N° 3
P. 501-519 - septembre 2008 Retour au numéro
Article précédent
- Endovascular Stenting of Thoracic Aortic Aneurysm
- Jacob T. Gutsche, Wilson Szeto, Albert T. Cheung
- Brain Protection in Cardiac Surgery
- Kelly Grogan, Joshua Stearns, Charles W. Hogue
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?